Oklahoma 2024 Regular Session

Oklahoma House Bill HB2281 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	An Act
2		-	ENROLLED HOUSE
	1	+
	2	+
	3	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 1 1
	4	+	2
	5	+	3
	6	+	4
	7	+	5
	8	+	6
	9	+	7
	10	+	8
	11	+	9
	12	+	10
	13	+	11
	14	+	12
	15	+	13
	16	+	14
	17	+	15
	18	+	16
	19	+	17
	20	+	18
	21	+	19
	22	+	20
	23	+	21
	24	+	22
	25	+	23
	26	+	24
	27	+
	28	+	ENGROSSED SENATE AMENDMENT
	29	+	TO
	30	+	ENGROSSED HOUSE
3	31		BILL NO. 2281 By: Echols of the House
4	32
5	33		and
6	34
7	35		Paxton of the Senate
8		-
9	36
10	37
11	38
12	39
13	40		An Act relating to public health and safety; amending
14	41		63 O.S. 2021, Section 2 -101, as amended by Section 4,
15	42		Chapter 265, O.S.L. 2022 (63 O.S. Supp. 2022, Section
16	43		2-101), which relates to the Uniform Controlled
17		-	Dangerous Substances Act; defining term; amending 63
18		-	O.S. 2021, Section 2 -406, which relates to penalties
19		-	for violating the Uniform Controlled Dangerous
20		-	Substances Act; making certain acts unlawful;
21		-	updating statutory language; updating statutory
22		-	reference; and declaring an emergency.
23		-
24		-
25		-
26		-
27		-	SUBJECT: Public health and safety
	44	+	Dangerous Substances Act; adding definition; amending
	45	+	63 O.S. 2021, Section 2 -406, which relates to
	46	+	penalties for violating the Uniform Controlled
	47	+	Dangerous Substances Act; making certain acts
	48	+	unlawful; and declaring an emergency.
	49	+
	50	+
	51	+
	52	+	AMENDMENT NO. 1. Page 1, strike the title, enacting clause and
	53	+	entire bill and insert
	54	+
	55	+
	56	+	“An Act relating to public health and safety;
	57	+	amending 63 O.S. 2021, Section 2 -101, as amended by
	58	+	Section 4, Chapter 265, O.S.L. 2022 (63 O.S. Supp.
	59	+	2022, Section 2-101), which relates to the Uniform
	60	+	Controlled Dangerous Substances Act; defining term;
	61	+	amending 63 O.S. 2021, Section 2 -406, which relates
	62	+	to penalties for violating the Uniform Controlled
	63	+	Dangerous Substances Act; making certain acts
	64	+	unlawful; updating statutory la nguage; updating
	65	+	statutory reference; and declaring an emergency.
	66	+
	67	+
	68	+
28	69
29	70		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA:
	71	+
	72	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 2 1
	73	+	2
	74	+	3
	75	+	4
	76	+	5
	77	+	6
	78	+	7
	79	+	8
	80	+	9
	81	+	10
	82	+	11
	83	+	12
	84	+	13
	85	+	14
	86	+	15
	87	+	16
	88	+	17
	89	+	18
	90	+	19
	91	+	20
	92	+	21
	93	+	22
	94	+	23
	95	+	24
30	96
31	97		SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-101, as
32	98		amended by Section 4 , Chapter 265, O.S.L. 2022 (63 O.S. Supp. 2022,
33	99		Section 2-101), is amended to read as follows:
34		-
35	100		Section 2-101. As used in the Uniform Controlled Dangerous
36	101		Substances Act:
37		-
38	102		1. “Administer” means the direct application of a controlled
39	103		dangerous substance, whether by injection, inhalation, ingestion or
40	104		any other means, to the body of a patient, animal or research
41	105		subject by:
42		-
43	106		a. a practitioner (or, in the presence of the
44	107		practitioner, by the authorized agent of the
45	108		practitioner), or
46		-	ENR. H. B. NO. 2281 Page 2
47	109		b. the patient or research subject at the direction and
48	110		in the presence of the practitioner;
49		-
50	111		2. “Agent” means a peace officer appointed by and who acts on
51	112		behalf of the Director of the Oklahoma State Bureau of Narcotics and
52	113		Dangerous Drugs Control or an authorized person who acts on behalf
53	114		of or at the direction of a person who manufactures, distributes,
54	115		dispenses, prescribes, administers or uses for scientific purposes
55	116		controlled dangerous substances but does not include a common or
56	117		contract carrier, public warehouser or employee thereof, or a person
57	118		required to register under the Uniform Controlled Dangerous
58	119		Substances Act;
59	120
	121	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 3 1
	122	+	2
	123	+	3
	124	+	4
	125	+	5
	126	+	6
	127	+	7
	128	+	8
	129	+	9
	130	+	10
	131	+	11
	132	+	12
	133	+	13
	134	+	14
	135	+	15
	136	+	16
	137	+	17
	138	+	18
	139	+	19
	140	+	20
	141	+	21
	142	+	22
	143	+	23
	144	+	24
	145	+
60	146		3. “Board” means the Advisory Board to the Director of the
61	147		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
62		-
63	148		4. “Bureau” means the Oklahoma State Bureau of Narcotics and
64	149		Dangerous Drugs Control;
65		-
66	150		5. “Coca leaves” includes cocaine and any compound,
67	151		manufacture, salt, derivative, mixture or preparation of coca
68	152		leaves, except derivatives of coca leaves which do not contain
69	153		cocaine or ecgonine;
70		-
71	154		6. “Commissioner” or “Director” means the Director of the
72	155		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
73		-
74	156		7. “Control” means to add, remove or change the placement of a
75	157		drug, substance or immediate precursor under the Uniform Controlled
76	158		Dangerous Substances Act;
77		-
78	159		8. “Controlled dangerous substance” means a drug, substance or
79	160		immediate precursor in Schedules I through V of the Uniform
80	161		Controlled Dangerous Substances Act or any drug, substance or
81	162		immediate precursor listed either temporarily or permanently as a
82	163		federally controlled substance. Any conflict between state and
83	164		federal law with regard to the particular schedule in which a
84	165		substance is listed shall be resolved in favor of state law;
85		-
86	166		9. “Counterfeit substance” means a controlled substance which,
87	167		or the container or labeling of which without authorization, bears
88	168		the trademark, trade name or other identifying marks, imprint,
89	169		number or device or any likeness thereof of a manufacturer,
	170	+
	171	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 4 1
	172	+	2
	173	+	3
	174	+	4
	175	+	5
	176	+	6
	177	+	7
	178	+	8
	179	+	9
	180	+	10
	181	+	11
	182	+	12
	183	+	13
	184	+	14
	185	+	15
	186	+	16
	187	+	17
	188	+	18
	189	+	19
	190	+	20
	191	+	21
	192	+	22
	193	+	23
	194	+	24
	195	+
90	196		distributor or dispenser other than the person who in fact
91		-	manufactured, distributed or dispensed the substance; ENR. H. B. NO. 2281 Page 3
92		-
	197	+	manufactured, distributed or dispensed the substance;
93	198		10. “Deliver” or “delivery” means the actual, constructive or
94	199		attempted transfer from one person to another of a controlled
95	200		dangerous substance or drug paraphernalia, whether or not there is
96	201		an agency relationship;
97		-
98	202		11. “Dispense” means to deliver a controlled dangerous
99	203		substance to an ultimate user or human research subject by or
100	204		pursuant to the lawful order of a practitioner, including the
101	205		prescribing, administering, packaging, labeling or compounding
102	206		necessary to prepare the substance for such distribution.
103	207		“Dispenser” is a practitioner who delivers a controlled dangerous
104	208		substance to an ultimate user or human research subject;
105		-
106	209		12. “Distribute” means to deliver other than by administering
107	210		or dispensing a controlled dangerous substance;
108		-
109	211		13. “Distributor” means a commercial entity engaged in the
110	212		distribution or reverse distribution of narcotics and dangerous
111	213		drugs and who complies with all regulations promulgated by the
112	214		federal Drug Enforcement Administration and the Oklahoma State
113	215		Bureau of Narcotics and Dangerous Drugs Control;
114		-
115	216		14. “Drug” means articles:
116		-
117	217		a. recognized in the official United States Pharmacopeia,
118	218		official Homeopathic Pharmacopoeia of the United
	219	+
	220	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 5 1
	221	+	2
	222	+	3
	223	+	4
	224	+	5
	225	+	6
	226	+	7
	227	+	8
	228	+	9
	229	+	10
	230	+	11
	231	+	12
	232	+	13
	233	+	14
	234	+	15
	235	+	16
	236	+	17
	237	+	18
	238	+	19
	239	+	20
	240	+	21
	241	+	22
	242	+	23
	243	+	24
	244	+
119	245		States, or official National Formulary, or any
120	246		supplement to any of them,
121		-
122	247		b. intended for use in the diagnosis, cure, mitigation,
123	248		treatment or prevention of disease in man or other
124	249		animals,
125		-
126	250		c. other than food, intended to affect the structure or
127	251		any function of the body of man or other animals, and
128		-
129	252		d. intended for use as a component of any article
130	253		specified in this paragraph;
131		-
132	254		provided, however, the term “drug” drug does not include devices or
133	255		their components, parts or accessories;
134		-
135	256		15. “Drug-dependent person” means a person who is using a
136		-	controlled dangerous substance and who is in a state of psychic or ~~ENR. H. B. NO. 2281 Page 4~~
	257	+	controlled dangerous substance and who is in a state of psychic or
137	258		physical dependence, or both, arising from administration of that
138	259		controlled dangerous substance on a continuous basis. Drug
139	260		dependence is characterized by behavioral and other responses which
140	261		include a strong compulsion to take the substance on a continuous
141	262		basis in order to experience its psychic effects, or to avoid the
142	263		discomfort of its absence;
143		-
144	264		16. “Home care agency” means any sole proprietorship,
145	265		partnership, association, corporation, or other organization which
146	266		administers, offers, or provides home care services, for a fee or
147	267		pursuant to a contract for such services, to clients in their place
148	268		of residence;
149	269
	270	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 6 1
	271	+	2
	272	+	3
	273	+	4
	274	+	5
	275	+	6
	276	+	7
	277	+	8
	278	+	9
	279	+	10
	280	+	11
	281	+	12
	282	+	13
	283	+	14
	284	+	15
	285	+	16
	286	+	17
	287	+	18
	288	+	19
	289	+	20
	290	+	21
	291	+	22
	292	+	23
	293	+	24
	294	+
150	295		17. “Home care services” means skilled or personal care
151	296		services provided to clients in their place of residence for a fee;
152		-
153	297		18. “Hospice” means a centrally administered, nonprofit or for-
154	298		profit, medically directed, nurse-coordinated program which provides
155	299		a continuum of home and inpatient care for the terminally ill
156	300		patient and the patient’s family. Such term shall also include a
157	301		centrally administered, nonprofit or for-profit, medically directed,
158	302		nurse-coordinated program if such program is licensed pursuant to
159	303		the provisions of the Uniform Controlled Dangerous Substances Act.
160	304		A hospice program offers palliative and supportive care to meet the
161	305		special needs arising out of the physical, emotional and spiritual
162	306		stresses which are experienced during the final stages of illness
163	307		and during dying and bereavement. This care is available twenty-
164	308		four (24) hours a day, seven (7) days a week, and is provided on the
165	309		basis of need, regardless of ability to pay. “Class A” Hospice
166	310		refers to Medicare-certified hospices. “Class B” refers to all
167	311		other providers of hospice services;
168		-
169	312		19. “Imitation controlled substance” means a substance that is
170	313		not a controlled dangerous substance, which by dosage unit
171	314		appearance, color, shape, size, markings or by representations made,
172	315		would lead a reasonable person to believe that the substance is a
173	316		controlled dangerous substance. In the event the appearance of the
174	317		dosage unit is not reasonably sufficient to establish that the
175	318		substance is an “imitation controlled substance” imitation
	319	+
	320	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 7 1
	321	+	2
	322	+	3
	323	+	4
	324	+	5
	325	+	6
	326	+	7
	327	+	8
	328	+	9
	329	+	10
	330	+	11
	331	+	12
	332	+	13
	333	+	14
	334	+	15
	335	+	16
	336	+	17
	337	+	18
	338	+	19
	339	+	20
	340	+	21
	341	+	22
	342	+	23
	343	+	24
	344	+
176	345		controlled substance, the court or authority concerned should
177	346		consider, in addition to all oth er factors, the following factors as
178	347		related to “representations made” in determining whether the
179	348		substance is an “imitation controlled substance” imitation
180	349		controlled substance :
181		-	ENR. H. B. NO. 2281 Page 5
182	350		a. statements made by an owner or by any other person in
183	351		control of the substance concerning the nature of the
184	352		substance, or its use or effect,
185		-
186	353		b. statements made to the recipient that the substance
187	354		may be resold for inordinate profit,
188		-
189	355		c. whether the substance is packaged in a manner normally
190	356		used for illicit controlled substances,
191		-
192	357		d. evasive tactics or actions utilized by the owner or
193	358		person in control of the substance to avoid detection
194	359		by law enforcement authorities,
195		-
196	360		e. prior convictions, if any, of an owner, or any other
197	361		person in control of the object, under state or
198	362		federal law related to controlled substances or fraud,
199	363		and
200		-
201	364		f. the proximity of the substances to controlled
202	365		dangerous substances;
203		-
204	366		20. “Immediate precursor” means a substance which the Director
205	367		has found to be and by regulation designates as being the principal
206	368		compound commonly used or produced primarily for use, and which is
	369	+
	370	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 8 1
	371	+	2
	372	+	3
	373	+	4
	374	+	5
	375	+	6
	376	+	7
	377	+	8
	378	+	9
	379	+	10
	380	+	11
	381	+	12
	382	+	13
	383	+	14
	384	+	15
	385	+	16
	386	+	17
	387	+	18
	388	+	19
	389	+	20
	390	+	21
	391	+	22
	392	+	23
	393	+	24
	394	+
207	395		an immediate chemical intermediary used, or likely to be used, in
208	396		the manufacture of a controlled dangerous substance, the control of
209	397		which is necessary to prevent, curtail or limit such manufacture;
210		-
211	398		21. “Laboratory” means a laboratory approved by the Director as
212	399		proper to be entrusted with the custody of controlled dangerous
213	400		substances and the use of controlled dangerous substances for
214	401		scientific and medical purposes and for purposes of instruction;
215		-
216	402		22. “Manufacture” means the production, preparation,
217	403		propagation, compounding or processing of a controlled dangerous
218	404		substance, either directly or indirectly by extraction from
219	405		substances of natural or synthetic origin, or independently by means
220	406		of chemical synthesis or by a combination of extraction and chemical
221	407		synthesis. “Manufacturer” includes any person who packages,
222	408		repackages or labels any container of any controlled dangerous
223	409		substance, except practitioners who dispense or compound
224	410		prescription orders for delivery to the ultimate consumer;
225		-	ENR. H. B. NO. 2281 Page 6
226	411		23. “Marijuana” means all parts of the plant Cannabis sativa
227	412		L., whether growing or not; the seeds thereof; the resin extracted
228	413		from any part of such plant; and every compound, manufacture, salt,
229	414		derivative, mixture or preparation of such plant, its seeds or
230	415		resin, but shall not include:
231		-
232	416		a. the mature stalks of such plant or fiber produced from
233	417		such stalks,
	418	+
	419	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 9 1
	420	+	2
	421	+	3
	422	+	4
	423	+	5
	424	+	6
	425	+	7
	426	+	8
	427	+	9
	428	+	10
	429	+	11
	430	+	12
	431	+	13
	432	+	14
	433	+	15
	434	+	16
	435	+	17
	436	+	18
	437	+	19
	438	+	20
	439	+	21
	440	+	22
	441	+	23
	442	+	24
234	443
235	444		b. oil or cake made from the seeds of such plant,
236	445		including cannabidiol derived from the seeds of the
237	446		marijuana plant,
238		-
239	447		c. any other compound, manufacture, salt, derivative,
240	448		mixture or preparation of such mature stalks (except
241	449		the resin extracted therefrom), including cannabidiol
242	450		derived from mature stalks, fiber, oil or cake,
243		-
244	451		d. the sterilized seed of such plant which is incapable
245	452		of germination,
246		-
247	453		e. for any person participating in a clinical trial to
248	454		administer cannabidiol for the treatment of severe
249	455		forms of epilepsy pursuant to Section 2-802 of this
250	456		title, a drug or substance approved by the federal
251	457		Food and Drug Administration for use by those
252	458		participants,
253		-
	459	+	f. for any person or the parents, legal guardians or
	460	+	caretakers of the person who have received a written
	461	+	certification from a physician licensed in this state
	462	+	that the person has been diagnosed by a physician as
	463	+	having Lennox-Gastaut syndrome, Dravet syndrome, also
	464	+	known as severe myoclonic epilepsy of infancy, or any
	465	+	other severe form of epilepsy that is not adequately
	466	+	treated by traditional medical therapies, spasticity
	467	+	due to multiple sclerosis or due to paraplegia,
	468	+
	469	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 10 1
	470	+	2
	471	+	3
	472	+	4
	473	+	5
	474	+	6
	475	+	7
	476	+	8
	477	+	9
	478	+	10
	479	+	11
	480	+	12
	481	+	13
	482	+	14
	483	+	15
	484	+	16
	485	+	17
	486	+	18
	487	+	19
	488	+	20
	489	+	21
	490	+	22
	491	+	23
	492	+	24
	493	+
	494	+	intractable nausea and vomiting, appetite stimulation
	495	+	with chronic wasting diseases, the substance
	496	+	cannabidiol, a nonpsychoactive cannabinoid, found in
	497	+	the plant Cannabis sativa L. or any other preparation
	498	+	thereof, that has a tetrahydrocannabinol concentration
	499	+	of not more than three-tenths of one percent (0.3%)
	500	+	and that is delivered to the patient in the form of a
	501	+	liquid,
	502	+	g. any federal Food-and-Drug-Administration-approved drug
	503	+	or substance, or
	504	+	h. industrial hemp, from the plant Cannabis sativa L. and
	505	+	any part of such plant, whether growing or not, with a
	506	+	delta-9 tetrahydrocannabinol concentration of not more
	507	+	than three-tenths of one percent (0.3%) on a dry-
	508	+	weight basis which shall only be grown pursuant to the
	509	+	Oklahoma Industrial Hemp Program and may be shipped
	510	+	intrastate and interstate;
	511	+	24. “Medical purpose” means an intention to utilize a
	512	+	controlled dangerous substance for physical or mental treatment, for
	513	+	diagnosis, or for the prevention of a disease condition not in
	514	+	violation of any state or federal law and not for the purpose of
	515	+	satisfying physiological or psychological depe ndence or other abuse;
	516	+	25. “Mid-level practitioner” means an Advanced Practice
	517	+	Registered Nurse as defined and within parameters specified in
	518	+
	519	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 11 1
	520	+	2
	521	+	3
	522	+	4
	523	+	5
	524	+	6
	525	+	7
	526	+	8
	527	+	9
	528	+	10
	529	+	11
	530	+	12
	531	+	13
	532	+	14
	533	+	15
	534	+	16
	535	+	17
	536	+	18
	537	+	19
	538	+	20
	539	+	21
	540	+	22
	541	+	23
	542	+	24
	543	+
	544	+	Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
	545	+	animal euthanasia technician as defined in Se ction 698.2 of Title 59
	546	+	of the Oklahoma Statutes, or an animal control officer registered by
	547	+	the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
	548	+	under subsection B of Section 2-301 of this title within the
	549	+	parameters of such officer’s duties under Sections 501 through 508
	550	+	of Title 4 of the Oklahoma Statutes;
	551	+	26. “Narcotic drug” means any of the following, whether
	552	+	produced directly or indirectly by extraction from substances of
	553	+	vegetable origin, or independently by means of chemical synthesis ,
	554	+	or by a combination of extraction and chemical synthesis:
	555	+	a. opium, coca leaves and opiates,
	556	+	b. a compound, manufacture, salt, derivative or
	557	+	preparation of opium, coca leaves or opiates,
	558	+	c. cocaine, its salts, optical and geometric isomers, and
	559	+	salts of isomers,
	560	+	d. ecgonine, its derivatives, their salts, isomers and
	561	+	salts of isomers, and
	562	+	e. a substance, and any compound, manufacture, salt,
	563	+	derivative or preparation thereof, which is chemically
	564	+	identical with any of the substances referred to in
	565	+	subparagraphs a through d of this paragraph, except
	566	+	that the words “narcotic drug” narcotic drug as used
	567	+	in Section 2-101 et seq. of this title shall not
	568	+
	569	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 12 1
	570	+	2
	571	+	3
	572	+	4
	573	+	5
	574	+	6
	575	+	7
	576	+	8
	577	+	9
	578	+	10
	579	+	11
	580	+	12
	581	+	13
	582	+	14
	583	+	15
	584	+	16
	585	+	17
	586	+	18
	587	+	19
	588	+	20
	589	+	21
	590	+	22
	591	+	23
	592	+	24
	593	+
	594	+	include decocainized coca leaves or extracts of coca
	595	+	leaves, which extracts do not contain cocaine or
	596	+	ecgonine;
	597	+	27. “Opiate” or “opioid” means any Schedule II, III, IV or V
	598	+	substance having an addiction-forming or addiction-sustaining
	599	+	liability similar to morphine or being capable of conversion into a
	600	+	drug having such addiction-forming or addiction-sustaining
	601	+	liability. The terms do not include, unless specifically designated
	602	+	as controlled under the Uniform Controlled Dangerous Substances Act,
	603	+	the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
	604	+	salts (dextromethorphan). The terms do include the racemic and
	605	+	levorotatory forms;
	606	+	28. “Opium poppy” means the plant of the species Papaver
	607	+	somniferum L., except the seeds thereof;
	608	+	29. “Peace officer” means a police officer, sheriff, deputy
	609	+	sheriff, district attorney’s investigator, investigator from the
	610	+	Office of the Attorney General, or any other person elected or
	611	+	appointed by law to enforce any of the criminal laws of this state
	612	+	or of the United States;
	613	+	30. “Person” means an individual, corporation, government or
	614	+	governmental subdivision or agency, business trust, estat e, trust,
	615	+	partnership or association, or any other legal entity;
	616	+	31. “Poppy straw” means all parts, except the seeds, of the
	617	+	opium poppy, after mowing;
	618	+
	619	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 13 1
	620	+	2
	621	+	3
	622	+	4
	623	+	5
	624	+	6
	625	+	7
	626	+	8
	627	+	9
	628	+	10
	629	+	11
	630	+	12
	631	+	13
	632	+	14
	633	+	15
	634	+	16
	635	+	17
	636	+	18
	637	+	19
	638	+	20
	639	+	21
	640	+	22
	641	+	23
	642	+	24
	643	+
	644	+	32. “Practitioner” means:
	645	+	a. (1) a medical doctor or osteopathic physician,
	646	+	(2) a dentist,
	647	+	(3) a podiatrist,
	648	+	(4) an optometrist,
	649	+	(5) a veterinarian,
	650	+	(6) a physician assistant or Advanced Practice
	651	+	Registered Nurse under the supervision of a
	652	+	licensed medical doctor or osteopathic physician,
	653	+	(7) a scientific investigator, or
	654	+	(8) any other person,
	655	+	licensed, registered or otherwise permitted to
	656	+	prescribe, distribute, dispense, conduct research with
	657	+	respect to, use for scientific purposes or administer
	658	+	a controlled dangerous substance in the course of
	659	+	professional practice or research in this state, or
	660	+	b. a pharmacy, hospital, laboratory or other institution
	661	+	licensed, registered or otherwise permitted to
	662	+	distribute, dispense, conduct research with respect
	663	+	to, use for scientific purposes or administer a
	664	+	controlled dangerous substance in the course of
	665	+	professional practice or research in this state;
	666	+
	667	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 14 1
	668	+	2
	669	+	3
	670	+	4
	671	+	5
	672	+	6
	673	+	7
	674	+	8
	675	+	9
	676	+	10
	677	+	11
	678	+	12
	679	+	13
	680	+	14
	681	+	15
	682	+	16
	683	+	17
	684	+	18
	685	+	19
	686	+	20
	687	+	21
	688	+	22
	689	+	23
	690	+	24
	691	+
	692	+	33. “Production” includes the manufacture, planting,
	693	+	cultivation, growing or harvesting of a controlled dangerous
	694	+	substance;
	695	+	34. “State” means the State of Oklahoma or any other state of
	696	+	the United States;
	697	+	35. “Ultimate user” means a person who lawfully possesses a
	698	+	controlled dangerous substance for the person’s own use or for the
	699	+	use of a member of the person’s household or for administration to
	700	+	an animal owned by the person or by a member of the person’s
	701	+	household;
	702	+	36. “Drug paraphernalia” means all equipment, products and
	703	+	materials of any kind which are used, intended for use, or fashioned
	704	+	specifically for use in planting, propagating, cultivating, growing,
	705	+	harvesting, manufacturing, compounding, converting, producin g,
	706	+	processing, preparing, testing, analyzing, packaging, repackaging,
	707	+	storing, containing, concealing, injecting, ingesting, inhaling or
	708	+	otherwise introducing into the human body, a controlled dangerous
	709	+	substance in violation of the Uniform Controlled Dang erous
	710	+	Substances Act including, but not limited to:
	711	+	a. kits used, intended for use, or fashioned specifically
	712	+	for use in planting, propagating, cultivating, growing
	713	+	or harvesting of any species of plant which is a
	714	+	controlled dangerous substance or from whi ch a
	715	+	controlled dangerous substance can be derived,
	716	+
	717	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 15 1
	718	+	2
	719	+	3
	720	+	4
	721	+	5
	722	+	6
	723	+	7
	724	+	8
	725	+	9
	726	+	10
	727	+	11
	728	+	12
	729	+	13
	730	+	14
	731	+	15
	732	+	16
	733	+	17
	734	+	18
	735	+	19
	736	+	20
	737	+	21
	738	+	22
	739	+	23
	740	+	24
	741	+
	742	+	b. kits used, intended for use, or fashioned specifically
	743	+	for use in manufacturing, compounding, converting,
	744	+	producing, processing or preparing controlled
	745	+	dangerous substances,
	746	+	c. isomerization devices us ed, intended for use, or
	747	+	fashioned specifically for use in increasing the
	748	+	potency of any species of plant which is a controlled
	749	+	dangerous substance,
	750	+	d. testing equipment used, intended for use, or fashioned
	751	+	specifically for use in identifying, or in analyz ing
	752	+	the strength, effectiveness or purity of controlled
	753	+	dangerous substances,
	754	+	e. scales and balances used, intended for use, or
	755	+	fashioned specifically for use in weighing or
	756	+	measuring controlled dangerous substances,
	757	+	f. diluents and adulterants, such as qu inine
	758	+	hydrochloride, mannitol, mannite, dextrose and
	759	+	lactose, used, intended for use, or fashioned
	760	+	specifically for use in cutting controlled dangerous
	761	+	substances,
	762	+	g. separation gins and sifters used, intended for use, or
	763	+	fashioned specifically for use in removing twigs and
	764	+	seeds from, or in otherwise cleaning or refining,
	765	+	marijuana,
	766	+
	767	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 16 1
	768	+	2
	769	+	3
	770	+	4
	771	+	5
	772	+	6
	773	+	7
	774	+	8
	775	+	9
	776	+	10
	777	+	11
	778	+	12
	779	+	13
	780	+	14
	781	+	15
	782	+	16
	783	+	17
	784	+	18
	785	+	19
	786	+	20
	787	+	21
	788	+	22
	789	+	23
	790	+	24
	791	+
	792	+	h. blenders, bowls, containers, spoons and mixing devices
	793	+	used, intended for use, or fashioned specifically for
	794	+	use in compounding controlled dangerous substances,
	795	+	i. capsules, balloons, envelopes and other containers
	796	+	used, intended for use, or fashioned specifically for
	797	+	use in packaging small quantities of controlled
	798	+	dangerous substances,
	799	+	j. containers and other objects used, intended for use,
	800	+	or fashioned specifically for use in parenterally
	801	+	injecting controlled dangerous substances into the
	802	+	human body,
	803	+	k. hypodermic syringes, needles and other objects used,
	804	+	intended for use, or fashioned specifically for use in
	805	+	parenterally injecting controlled dangerous substances
	806	+	into the human body,
	807	+	l. objects used, intended for use, or fashioned
	808	+	specifically for use in ingesting, inhaling or
	809	+	otherwise introducing marijuana, cocaine, hashish or
	810	+	hashish oil into the human body, such as:
	811	+	(1) metal, wooden, acrylic, glass, stone, plastic or
	812	+	ceramic pipes with or without screens, permanent
	813	+	screens, hashish heads or punctured metal bowls,
	814	+	(2) water pipes,
	815	+	(3) carburetion tubes and devices,
	816	+
	817	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 17 1
	818	+	2
	819	+	3
	820	+	4
	821	+	5
	822	+	6
	823	+	7
	824	+	8
	825	+	9
	826	+	10
	827	+	11
	828	+	12
	829	+	13
	830	+	14
	831	+	15
	832	+	16
	833	+	17
	834	+	18
	835	+	19
	836	+	20
	837	+	21
	838	+	22
	839	+	23
	840	+	24
	841	+
	842	+	(4) smoking and carburetion masks,
	843	+	(5) roach clips, meaning objects used to hold burning
	844	+	material, such as a marijuana cigarette, that has
	845	+	become too small or too short to be held in the
	846	+	hand,
	847	+	(6) miniature cocaine spoons and cocaine vials,
	848	+	(7) chamber pipes,
	849	+	(8) carburetor pipes,
	850	+	(9) electric pipes,
	851	+	(10) air-driven pipes,
	852	+	(11) chillums,
	853	+	(12) bongs, or
	854	+	(13) ice pipes or chillers,
	855	+	m. all hidden or novelty pipes, and
	856	+	n. any pipe that has a tobacco bowl or chamber of less
	857	+	than one-half (1/2) inch in diameter in which there is
	858	+	any detectable residue of any controlled dangerous
	859	+	substance as defined in this section or any other
	860	+	substances not legal for possession or use;
	861	+	provided, however, the term “drug paraphernalia” drug paraphernalia
	862	+	shall not include separation gins intended for use in preparing tea
	863	+	or spice, clamps used for constructing electrical equipment, water
	864	+	pipes designed for ornamentation in which no detectable amount of an
	865	+	illegal substance is found or pipes designed and used solely for
	866	+
	867	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 18 1
	868	+	2
	869	+	3
	870	+	4
	871	+	5
	872	+	6
	873	+	7
	874	+	8
	875	+	9
	876	+	10
	877	+	11
	878	+	12
	879	+	13
	880	+	14
	881	+	15
	882	+	16
	883	+	17
	884	+	18
	885	+	19
	886	+	20
	887	+	21
	888	+	22
	889	+	23
	890	+	24
	891	+
	892	+	smoking tobacco, traditional pipes of an American Indian tribal
	893	+	religious ceremony, or antique pipes that are thirty (30) years of
	894	+	age or older;
	895	+	37. a. “Synthetic controlled substance” means a substance:
	896	+	(1) the chemical structure of which is substantially
	897	+	similar to the chemical structure of a controlled
	898	+	dangerous substance in Schedule I or II,
	899	+	(2) which has a stimulant, depressant, or
	900	+	hallucinogenic effect on the central nervous
	901	+	system that is substantially similar to or
	902	+	greater than the stimulant, depressant or
	903	+	hallucinogenic effect on the central nervous
	904	+	system of a controlled dangerous substance in
	905	+	Schedule I or II, or
	906	+	(3) with respect to a particular person, which such
	907	+	person represents or intends to have a stimulant,
	908	+	depressant, or hallucinogenic effect on the
	909	+	central nervous system that is substantially
	910	+	similar to or greater than the stimulant,
	911	+	depressant, or hallucinogenic effect on the
	912	+	central nervous system of a controlled dangerous
	913	+	substance in Schedule I or II.
	914	+	b. The designation of gamma butyrolactone or any other
	915	+	chemical as a precursor, pursuant to Section 2-322 of
	916	+
	917	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 19 1
	918	+	2
	919	+	3
	920	+	4
	921	+	5
	922	+	6
	923	+	7
	924	+	8
	925	+	9
	926	+	10
	927	+	11
	928	+	12
	929	+	13
	930	+	14
	931	+	15
	932	+	16
	933	+	17
	934	+	18
	935	+	19
	936	+	20
	937	+	21
	938	+	22
	939	+	23
	940	+	24
	941	+
	942	+	this title, does not preclude a finding pursuant to
	943	+	subparagraph a of this paragraph that the chemical is
	944	+	a synthetic controlled substance.
	945	+	c. “Synthetic controlled substance” does not include:
	946	+	(1) a controlled dangerous substance,
	947	+	(2) any substance for which there is an approved new
	948	+	drug application,
	949	+	(3) with respect to a particular person any
	950	+	substance, if an exemption is in effect for
	951	+	investigational use, for that person under the
	952	+	provisions of Section 505 of the Federal Food,
	953	+	Drug and Cosmetic Act, Title 21 of the United
	954	+	States Code, Section 355, to the extent conduct
	955	+	with respect to such substance is pursuant to
	956	+	such exemption, or
	957	+	(4) any substance to the extent not intended for
	958	+	human consumption before such an exemption takes
	959	+	effect with respect to that substance.
	960	+	d. Prima facie evidence that a substance containing
	961	+	salvia divinorum has been enhanced, concentrated or
	962	+	chemically or physically altered shall give rise to a
	963	+	rebuttable presumption that the substance is a
	964	+	synthetic controlled substance;
	965	+
	966	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 20 1
	967	+	2
	968	+	3
	969	+	4
	970	+	5
	971	+	6
	972	+	7
	973	+	8
	974	+	9
	975	+	10
	976	+	11
	977	+	12
	978	+	13
	979	+	14
	980	+	15
	981	+	16
	982	+	17
	983	+	18
	984	+	19
	985	+	20
	986	+	21
	987	+	22
	988	+	23
	989	+	24
	990	+
	991	+	38. “Tetrahydrocannabinols” means all substances that have been
	992	+	chemically synthesized to emulate the tetrahydrocannabinols of
	993	+	marijuana, specifically including any tetrahydrocannabinols derived
	994	+	from industrial hemp;
	995	+	39. “Isomer” means the optical isomer, except as used in
	996	+	subsections C and F of Section 2-204 of this title an d paragraph 4
	997	+	of subsection A of Section 2-206 of this title. As used in
	998	+	subsections C and F of Section 2-204 of this title, “isomer” isomer
	999	+	means the optical, positional or geometric isomer. As used in
	1000	+	paragraph 4 of subsection A of Section 2-206 of this title, the term
	1001	+	“isomer” isomer means the optical or geometric isomer;
	1002	+	40. “Hazardous materials” means materials, whether solid,
	1003	+	liquid or gas, which are toxic to human, animal, aquatic or plant
	1004	+	life, and the disposal of which materials is controlled by state or
	1005	+	federal guidelines;
	1006	+	41. “Anhydrous ammonia” means any substance that exhibits
	1007	+	cryogenic evaporative behavior and tests positive for ammonia;
	1008	+	42. “Acute pain” means pain, whether resulting from disease,
	1009	+	accidental or intentional trauma or other cause, that the
	1010	+	practitioner reasonably expects to last only a short period of time.
	1011	+	“Acute pain” Acute pain does not include chronic pain, pain being
	1012	+	treated as part of cancer care, hospice or other end-of-life care,
	1013	+	or pain being treated as part of palliative care;
	1014	+
	1015	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 21 1
	1016	+	2
	1017	+	3
	1018	+	4
	1019	+	5
	1020	+	6
	1021	+	7
	1022	+	8
	1023	+	9
	1024	+	10
	1025	+	11
	1026	+	12
	1027	+	13
	1028	+	14
	1029	+	15
	1030	+	16
	1031	+	17
	1032	+	18
	1033	+	19
	1034	+	20
	1035	+	21
	1036	+	22
	1037	+	23
	1038	+	24
	1039	+
	1040	+	43. “Chronic pain” means pain that persists beyond the usual
	1041	+	course of an acute disease or healing of an injury. “Chronic pain”
	1042	+	Chronic pain may or may not be associated with an acute or chronic
	1043	+	pathologic process that causes continuous or intermittent pain over
	1044	+	months or years;
	1045	+	44. “Initial prescription” means a prescription issued to a
	1046	+	patient who:
	1047	+	a. has never previously been issued a prescription for
	1048	+	the drug or its pharmaceutical equivalent in the past
	1049	+	year, or
	1050	+	b. requires a prescription for the drug or its
	1051	+	pharmaceutical equivalent due to a surgical procedure
	1052	+	or new acute event and has previously had a
	1053	+	prescription for the drug or its pharmaceutical
	1054	+	equivalent within the past year.
	1055	+	When determining whether a patient was previously issued a
	1056	+	prescription for a drug or its pha rmaceutical equivalent, the
	1057	+	practitioner shall consult with the patient and review the medical
	1058	+	record and prescription monitoring information of the patient;
	1059	+	45. “Patient-provider agreement” means a written contract or
	1060	+	agreement that is executed between a practitioner and a patient,
	1061	+	prior to the commencement of treatment for chronic pain using an
	1062	+	opioid drug as a means to:
	1063	+
	1064	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 22 1
	1065	+	2
	1066	+	3
	1067	+	4
	1068	+	5
	1069	+	6
	1070	+	7
	1071	+	8
	1072	+	9
	1073	+	10
	1074	+	11
	1075	+	12
	1076	+	13
	1077	+	14
	1078	+	15
	1079	+	16
	1080	+	17
	1081	+	18
	1082	+	19
	1083	+	20
	1084	+	21
	1085	+	22
	1086	+	23
	1087	+	24
	1088	+
	1089	+	a. explain the possible risk of development of physical
	1090	+	or psychological dependence in the patient and prevent
	1091	+	the possible development of addiction,
	1092	+	b. document the understanding of both the practitioner
	1093	+	and the patient regarding the patient-provider
	1094	+	agreement of the patient,
	1095	+	c. establish the rights of the patient in association
	1096	+	with treatment and the obligations of the patient in
	1097	+	relation to the responsible use, discontinuation of
	1098	+	use, and storage of opioid drugs, including any
	1099	+	restrictions on the refill of prescriptions or the
	1100	+	acceptance of opioid prescriptions from practitioners,
	1101	+	d. identify the specific medications and other modes of
	1102	+	treatment, including physical therapy or exercise,
	1103	+	relaxation or psychological counseling, that are
	1104	+	included as a part of the patient-provider agreement,
	1105	+	e. specify the measures the practitioner may employ to
	1106	+	monitor the compliance of the patient including , but
	1107	+	not limited to, random specimen screens and pill
	1108	+	counts, and
	1109	+	f. delineate the process for terminating the agreement,
	1110	+	including the consequences if the practitioner has
	1111	+	reason to believe that the patient is not complying
	1112	+	with the terms of the agreemen t. Compliance with the
	1113	+
	1114	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 23 1
	1115	+	2
	1116	+	3
	1117	+	4
	1118	+	5
	1119	+	6
	1120	+	7
	1121	+	8
	1122	+	9
	1123	+	10
	1124	+	11
	1125	+	12
	1126	+	13
	1127	+	14
	1128	+	15
	1129	+	16
	1130	+	17
	1131	+	18
	1132	+	19
	1133	+	20
	1134	+	21
	1135	+	22
	1136	+	23
	1137	+	24
	1138	+
	1139	+	“consent items” shall constitute a valid, informed
	1140	+	consent for opioid therapy. The practitioner shall be
	1141	+	held harmless from civil litigation for failure to
	1142	+	treat pain if the event occurs because of nonadherence
	1143	+	by the patient with any of the provisions of the
	1144	+	patient-provider agreement;
	1145	+	46. “Serious illness” means a medical illness or physical
	1146	+	injury or condition that substantially affects quality of life for
	1147	+	more than a short period of time. “Serious illness” Serious illness
	1148	+	includes, but is not limited to, Alzheimer’s disease or related
	1149	+	dementias, lung disease, cancer, heart failure, renal failure, liver
	1150	+	failure or chronic, unremitting or intractable pain such as
	1151	+	neuropathic pain; and
	1152	+	47. “Surgical procedure” means a procedure that is performed
	1153	+	for the purpose of structurally altering the human body by incision
	1154	+	or destruction of tissues as part of the practice of medicine. This
	1155	+	term includes the diagnostic or therapeutic treatment of conditions
	1156	+	or disease processes by use of instruments such as lasers,
	1157	+	ultrasound, ionizing, radiation, scalpels, probes or needles that
	1158	+	cause localized alteration or transportation of live human tissue by
	1159	+	cutting, burning, vaporizing, freezing, suturing, probing or
	1160	+	manipulating by closed reduction for major dislocat ions or
	1161	+	fractures, or otherwise altering by any mechanical, thermal, light-
	1162	+	based, electromagnetic or chemical means; and
	1163	+
	1164	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 24 1
	1165	+	2
	1166	+	3
	1167	+	4
	1168	+	5
	1169	+	6
	1170	+	7
	1171	+	8
	1172	+	9
	1173	+	10
	1174	+	11
	1175	+	12
	1176	+	13
	1177	+	14
	1178	+	15
	1179	+	16
	1180	+	17
	1181	+	18
	1182	+	19
	1183	+	20
	1184	+	21
	1185	+	22
	1186	+	23
	1187	+	24
	1188	+
	1189	+	48. “Straw person” or “straw party” also known as a “front”
	1190	+	means a third party who:
	1191	+	a. is put up in name only to take part in a transact ion
	1192	+	or otherwise is a nominal party to a transaction,
	1193	+	b. acts on behalf of another person to obtain title to
	1194	+	property and executes documents and instruments the
	1195	+	principal may direct respecting property, or
	1196	+	c. purchases property for another for the purpose of
	1197	+	concealing the identity of the real purchaser or to
	1198	+	accomplish some purpose otherwise in violation of
	1199	+	Oklahoma Statutes.
	1200	+	SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -406, is
	1201	+	amended to read as follows:
	1202	+	Section 2-406. A. It shall be unlawful for any registrant
	1203	+	knowingly or intentionally:
	1204	+	1. To distribute, other than by dispensing or as otherwise
	1205	+	authorized by this act the Uniform Controlled Dangerous Substances
	1206	+	Act, a controlled dangerous substance classified in Sc hedules I or
	1207	+	II, in the course of his or her legitimate business, except pursuant
	1208	+	to an order form as required by Section 2 -308 of this title;
	1209	+	2. To use in the course of the manufacture or distribution of a
	1210	+	controlled dangerous substance a registration nu mber which is
	1211	+	fictitious, revoked, suspended or issued to another person;
	1212	+
	1213	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 25 1
	1214	+	2
	1215	+	3
	1216	+	4
	1217	+	5
	1218	+	6
	1219	+	7
	1220	+	8
	1221	+	9
	1222	+	10
	1223	+	11
	1224	+	12
	1225	+	13
	1226	+	14
	1227	+	15
	1228	+	16
	1229	+	17
	1230	+	18
	1231	+	19
	1232	+	20
	1233	+	21
	1234	+	22
	1235	+	23
	1236	+	24
	1237	+
	1238	+	3. To acquire or obtain possession of a controlled dangerous
	1239	+	substance by misrepresentation, fraud, forgery, deception or
	1240	+	subterfuge;
	1241	+	4. To furnish false or fraudulent material inf ormation in, or
	1242	+	omit any material information from, any application, report, or
	1243	+	other document required to be kept or filed under this act the
	1244	+	Uniform Controlled Dangerous Substances Act , or any record required
	1245	+	to be kept by this act the Uniform Controlled Dangerous Substances
	1246	+	Act; and
	1247	+	5. To make, distribute, or possess any punch, die, plate,
	1248	+	stone, or other thing designed to print, imprint, or reproduce the
	1249	+	trademark, trade name, or other identifying mark, imprint, or device
	1250	+	of another or any likeness of any of the foregoing upon any drug or
	1251	+	container or labeling thereof so as to render such drug a
	1252	+	counterfeit controlled dangerous substance; and
	1253	+	6. To purchase, or attempt, endeavor, or conspire to obtain or
	1254	+	purchase, any license or registration require d to distribute,
	1255	+	possess, prescribe, or manufacture any controlled dangerous
	1256	+	substance on behalf of, or at the request or demand of, any other
	1257	+	person through the use of a straw person or straw party.
	1258	+	B. Any person who vi olates this section is guilty of a felony
	1259	+	punishable by imprisonment for not more than twenty (20) years or a
	1260	+	fine of not more than Two Hundred Fifty Thousand Dollars
	1261	+	($250,000.00), or both.
	1262	+
	1263	+	ENGR. S. A. TO ENGR. H. B. NO. 2281 Page 26 1
	1264	+	2
	1265	+	3
	1266	+	4
	1267	+	5
	1268	+	6
	1269	+	7
	1270	+	8
	1271	+	9
	1272	+	10
	1273	+	11
	1274	+	12
	1275	+	13
	1276	+	14
	1277	+	15
	1278	+	16
	1279	+	17
	1280	+	18
	1281	+	19
	1282	+	20
	1283	+	21
	1284	+	22
	1285	+	23
	1286	+	24
	1287	+
	1288	+	C. Any person convicted of a second or subsequent violation of
	1289	+	this section is punishable by a term of imprisonme nt twice that
	1290	+	otherwise authorized and by twice the fine otherwise authorized.
	1291	+	Convictions for second or subsequent violations of this section
	1292	+	shall not be subject to statutory provisions for suspended
	1293	+	sentences, deferred sentences, or probation.
	1294	+	D. Any person convicted of any offense described in this
	1295	+	section shall, in addition to any fi ne imposed, pay a special
	1296	+	assessment trauma-care fee of One Hundred Dollars ($100.00) to be
	1297	+	deposited into the Trauma Car e Assistance Revolving Fund created in
	1298	+	Section 1-2522 1-2530.9 of this title.
	1299	+	SECTION 3. It being immediately necessar y for the preservation
	1300	+	of the public peace, health or safety, an emergency is hereby
	1301	+	declared to exist, by reason whereof this act shall take effect and
	1302	+	be in full force from and after its passage and approval.”
	1303	+	Passed the Senate the 25th day of April, 2023.
	1304	+
	1305	+
	1306	+
	1307	+	Presiding Officer of the Senate
	1308	+
	1309	+
	1310	+	Passed the House of Representatives the ____ day of __________,
	1311	+	2023.
	1312	+
	1313	+
	1314	+
	1315	+	Presiding Officer of the House
	1316	+	of Representatives
	1317	+
	1318	+	ENGR. H. B. NO. 2281 Page 1 1
	1319	+	2
	1320	+	3
	1321	+	4
	1322	+	5
	1323	+	6
	1324	+	7
	1325	+	8
	1326	+	9
	1327	+	10
	1328	+	11
	1329	+	12
	1330	+	13
	1331	+	14
	1332	+	15
	1333	+	16
	1334	+	17
	1335	+	18
	1336	+	19
	1337	+	20
	1338	+	21
	1339	+	22
	1340	+	23
	1341	+	24
	1342	+
	1343	+	ENGROSSED HOUSE
	1344	+	BILL NO. 2281 By: Echols of the House
	1345	+
	1346	+	and
	1347	+
	1348	+	Paxton of the Senate
	1349	+
	1350	+
	1351	+
	1352	+
	1353	+
	1354	+
	1355	+	An Act relating to public health and safety; amending
	1356	+	63 O.S. 2021, Section 2 -101, as amended by Section 4,
	1357	+	Chapter 265, O.S.L. 2022 (63 O.S. Supp. 2022, Section
	1358	+	2-101), which relates to the Uniform Controlled
	1359	+	Dangerous Substances Act; adding definition; amending
	1360	+	63 O.S. 2021, Section 2 -406, which relates to
	1361	+	penalties for violating the Uniform Controlled
	1362	+	Dangerous Substances Act; making certain acts
	1363	+	unlawful; and declaring an emergency.
	1364	+
	1365	+
	1366	+
	1367	+
	1368	+
	1369	+	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
	1370	+	SECTION 4. AMENDATORY 63 O.S. 2021, Section 2 -101, as
	1371	+	amended by Section 4 , Chapter 265, O.S.L. 2022 (63 O.S. Supp. 2022,
	1372	+	Section 2-101), is amended to read as follows:
	1373	+	Section 2-101. As used in the Uniform Controlled Dangerous
	1374	+	Substances Act:
	1375	+	1. "Administer" means the direct application of a controlled
	1376	+	dangerous substance, whether by injection, inhalation, ingestion or
	1377	+	any other means, to the body of a patient, animal or research
	1378	+	subject by:
	1379	+
	1380	+	ENGR. H. B. NO. 2281 Page 2 1
	1381	+	2
	1382	+	3
	1383	+	4
	1384	+	5
	1385	+	6
	1386	+	7
	1387	+	8
	1388	+	9
	1389	+	10
	1390	+	11
	1391	+	12
	1392	+	13
	1393	+	14
	1394	+	15
	1395	+	16
	1396	+	17
	1397	+	18
	1398	+	19
	1399	+	20
	1400	+	21
	1401	+	22
	1402	+	23
	1403	+	24
	1404	+
	1405	+	a. a practitioner (or, in the presence of the
	1406	+	practitioner, by the authorized agent of the
	1407	+	practitioner), or
	1408	+	b. the patient or research subject at the direction and
	1409	+	in the presence of the practitioner;
	1410	+	2. "Agent" means a peace officer appointed by and who acts on
	1411	+	behalf of the Director of the Oklahoma State Bureau of Narcotics and
	1412	+	Dangerous Drugs Control or an authorized p erson who acts on behalf
	1413	+	of or at the direction of a person who manufactures, distributes,
	1414	+	dispenses, prescribes, administers or uses for scientific purposes
	1415	+	controlled dangerous substances but does not include a common or
	1416	+	contract carrier, public warehous er or employee thereof, or a person
	1417	+	required to register under the Uniform Controlled Dangerous
	1418	+	Substances Act;
	1419	+	3. "Board" means the Advisory Board to the Director of the
	1420	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
	1421	+	4. "Bureau" means the Oklahoma State Bureau of Narcotics and
	1422	+	Dangerous Drugs Control;
	1423	+	5. "Coca leaves" includes cocaine and any compound,
	1424	+	manufacture, salt, derivative, mixture or preparation of coca
	1425	+	leaves, except derivatives of coca leaves which do not contain
	1426	+	cocaine or ecgonine;
	1427	+	6. "Commissioner" or "Director" means the Director of the
	1428	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
	1429	+
	1430	+	ENGR. H. B. NO. 2281 Page 3 1
	1431	+	2
	1432	+	3
	1433	+	4
	1434	+	5
	1435	+	6
	1436	+	7
	1437	+	8
	1438	+	9
	1439	+	10
	1440	+	11
	1441	+	12
	1442	+	13
	1443	+	14
	1444	+	15
	1445	+	16
	1446	+	17
	1447	+	18
	1448	+	19
	1449	+	20
	1450	+	21
	1451	+	22
	1452	+	23
	1453	+	24
	1454	+
	1455	+	7. "Control" means to add, remove or change the placement of a
	1456	+	drug, substance or immediate precursor under the Uniform Co ntrolled
	1457	+	Dangerous Substances Act;
	1458	+	8. "Controlled dangerous substance" means a drug, substance or
	1459	+	immediate precursor in Schedules I through V of the Uniform
	1460	+	Controlled Dangerous Substances Act or any drug, substance or
	1461	+	immediate precursor listed either t emporarily or permanently as a
	1462	+	federally controlled substance. Any conflict between state and
	1463	+	federal law with regard to the particular schedule in which a
	1464	+	substance is listed shall be resolved in favor of state law;
	1465	+	9. "Counterfeit substance" means a controlled substance which,
	1466	+	or the container or labeling of which without authorization, bears
	1467	+	the trademark, trade name or other identifying marks, imprint,
	1468	+	number or device or any likeness thereof of a manufacturer,
	1469	+	distributor or dispenser other than the person who in fact
	1470	+	manufactured, distributed or dispensed the substance;
	1471	+	10. "Deliver" or "delivery" means the actual, constructive or
	1472	+	attempted transfer from one person to another of a controlled
	1473	+	dangerous substance or drug paraphernalia, whether or not there is
	1474	+	an agency relationship;
	1475	+	11. "Dispense" means to deliver a controlled dangerous
	1476	+	substance to an ultimate user or human research subject by or
	1477	+	pursuant to the lawful order of a practitioner, including the
	1478	+	prescribing, administering, packaging, labe ling or compounding
	1479	+
	1480	+	ENGR. H. B. NO. 2281 Page 4 1
	1481	+	2
	1482	+	3
	1483	+	4
	1484	+	5
	1485	+	6
	1486	+	7
	1487	+	8
	1488	+	9
	1489	+	10
	1490	+	11
	1491	+	12
	1492	+	13
	1493	+	14
	1494	+	15
	1495	+	16
	1496	+	17
	1497	+	18
	1498	+	19
	1499	+	20
	1500	+	21
	1501	+	22
	1502	+	23
	1503	+	24
	1504	+
	1505	+	necessary to prepare the substance for such distribution.
	1506	+	"Dispenser" is a practitioner who delivers a controlled dangerous
	1507	+	substance to an ultimate user or human research subject;
	1508	+	12. "Distribute" means to deliver other than by admin istering
	1509	+	or dispensing a controlled dangerous substance;
	1510	+	13. "Distributor" means a commercial entity engaged in the
	1511	+	distribution or reverse distribution of narcotics and dangerous
	1512	+	drugs and who complies with all regulations promulgated by the
	1513	+	federal Drug Enforcement Administration and the Oklahoma State
	1514	+	Bureau of Narcotics and Dangerous Drugs Control;
	1515	+	14. "Drug" means articles:
	1516	+	a. recognized in the official United States Pharmacopeia,
	1517	+	official Homeopathic Pharmacopoeia of the United
	1518	+	States, or official N ational Formulary, or any
	1519	+	supplement to any of them,
	1520	+	b. intended for use in the diagnosis, cure, mitigation,
	1521	+	treatment or prevention of disease in man or other
	1522	+	animals,
	1523	+	c. other than food, intended to affect the structure or
	1524	+	any function of the body of man or other animals, and
	1525	+	d. intended for use as a component of any article
	1526	+	specified in this paragraph;
	1527	+	provided, however, the term "drug" does not include devices or their
	1528	+	components, parts or accessories;
	1529	+
	1530	+	ENGR. H. B. NO. 2281 Page 5 1
	1531	+	2
	1532	+	3
	1533	+	4
	1534	+	5
	1535	+	6
	1536	+	7
	1537	+	8
	1538	+	9
	1539	+	10
	1540	+	11
	1541	+	12
	1542	+	13
	1543	+	14
	1544	+	15
	1545	+	16
	1546	+	17
	1547	+	18
	1548	+	19
	1549	+	20
	1550	+	21
	1551	+	22
	1552	+	23
	1553	+	24
	1554	+
	1555	+	15. "Drug-dependent person" means a person who i s using a
	1556	+	controlled dangerous substance and who is in a state of psychic or
	1557	+	physical dependence, or both, arising from administration of that
	1558	+	controlled dangerous substance on a continuous basis. Drug
	1559	+	dependence is characterized by behavioral and other r esponses which
	1560	+	include a strong compulsion to take the substance on a continuous
	1561	+	basis in order to experience its psychic effects, or to avoid the
	1562	+	discomfort of its absence;
	1563	+	16. "Home care agency" means any sole proprietorship,
	1564	+	partnership, association, corporation, or other organization which
	1565	+	administers, offers, or provides home care services, for a fee or
	1566	+	pursuant to a contract for such services, to clients in their place
	1567	+	of residence;
	1568	+	17. "Home care services" means skilled or personal care
	1569	+	services provided to clients in their place of residence for a fee;
	1570	+	18. "Hospice" means a centrally administered, nonprofit or for-
	1571	+	profit, medically directed, nurse-coordinated program which provides
	1572	+	a continuum of home and inpatient care for the terminally ill
	1573	+	patient and the patient's family. Such term shall also include a
	1574	+	centrally administered, nonprofit or for-profit, medically directed,
	1575	+	nurse-coordinated program if such program is licensed pursuant to
	1576	+	the provisions of the Uniform Controlled Dangerous Subst ances Act.
	1577	+	A hospice program offers palliative and supportive care to meet the
	1578	+	special needs arising out of the physical, emotional and spiritual
	1579	+
	1580	+	ENGR. H. B. NO. 2281 Page 6 1
	1581	+	2
	1582	+	3
	1583	+	4
	1584	+	5
	1585	+	6
	1586	+	7
	1587	+	8
	1588	+	9
	1589	+	10
	1590	+	11
	1591	+	12
	1592	+	13
	1593	+	14
	1594	+	15
	1595	+	16
	1596	+	17
	1597	+	18
	1598	+	19
	1599	+	20
	1600	+	21
	1601	+	22
	1602	+	23
	1603	+	24
	1604	+
	1605	+	stresses which are experienced during the final stages of illness
	1606	+	and during dying and bereavement. This care is available twenty-
	1607	+	four (24) hours a day, seven (7) days a week, and is provided on the
	1608	+	basis of need, regardless of ability to pay. "Class A" Hospice
	1609	+	refers to Medicare-certified hospices. "Class B" refers to all
	1610	+	other providers of hospice services;
	1611	+	19. "Imitation controlled substance" means a substance that is
	1612	+	not a controlled dangerous substance, which by dosage unit
	1613	+	appearance, color, shape, size, markings or by representations made,
	1614	+	would lead a reasonable person to believe that the substance is a
	1615	+	controlled dangerous substance. In the event the appearance of the
	1616	+	dosage unit is not reasonably sufficient to establish that the
	1617	+	substance is an "imitation controlled substance", the court or
	1618	+	authority concerned should consider, in addition to all oth er
	1619	+	factors, the following factors as related to "representations made"
	1620	+	in determining whether the substance is an "imitation controlled
	1621	+	substance":
	1622	+	a. statements made by an owner or by any other person in
	1623	+	control of the substance concerning the nature of the
	1624	+	substance, or its use or effect,
	1625	+	b. statements made to the recipient that the substance
	1626	+	may be resold for inordinate profit,
	1627	+	c. whether the substance is packaged in a manner normally
	1628	+	used for illicit controlled substances,
	1629	+
	1630	+	ENGR. H. B. NO. 2281 Page 7 1
	1631	+	2
	1632	+	3
	1633	+	4
	1634	+	5
	1635	+	6
	1636	+	7
	1637	+	8
	1638	+	9
	1639	+	10
	1640	+	11
	1641	+	12
	1642	+	13
	1643	+	14
	1644	+	15
	1645	+	16
	1646	+	17
	1647	+	18
	1648	+	19
	1649	+	20
	1650	+	21
	1651	+	22
	1652	+	23
	1653	+	24
	1654	+
	1655	+	d. evasive tactics or actions utilized by the owner or
	1656	+	person in control of the substance to avoid detection
	1657	+	by law enforcement authorities,
	1658	+	e. prior convictions, if any, of an owner, or any other
	1659	+	person in control of the object, under state or
	1660	+	federal law related to controlled substances or fraud,
	1661	+	and
	1662	+	f. the proximity of the substances to controlled
	1663	+	dangerous substances;
	1664	+	20. "Immediate precursor" means a substance which the Director
	1665	+	has found to be and by regulation designates as being the principal
	1666	+	compound commonly used or produced primarily for use, and which is
	1667	+	an immediate chemical intermediary used, or likely to be used, in
	1668	+	the manufacture of a controlled dangerous substance, the control of
	1669	+	which is necessary to prevent, curtail or limit such manufacture;
	1670	+	21. "Laboratory" means a laboratory approved by the Director as
	1671	+	proper to be entrusted with the custody of controlled dangerous
	1672	+	substances and the use of controlled dangerous substances for
	1673	+	scientific and medical purposes and for purposes of instruction;
	1674	+	22. "Manufacture" means the production, preparation,
	1675	+	propagation, compounding or processing of a controlled dangerous
	1676	+	substance, either directly or indirectly by extraction from
	1677	+	substances of natural or synthetic origin, or independently by means
	1678	+	of chemical synthesis or by a combination of extraction and chemical
	1679	+
	1680	+	ENGR. H. B. NO. 2281 Page 8 1
	1681	+	2
	1682	+	3
	1683	+	4
	1684	+	5
	1685	+	6
	1686	+	7
	1687	+	8
	1688	+	9
	1689	+	10
	1690	+	11
	1691	+	12
	1692	+	13
	1693	+	14
	1694	+	15
	1695	+	16
	1696	+	17
	1697	+	18
	1698	+	19
	1699	+	20
	1700	+	21
	1701	+	22
	1702	+	23
	1703	+	24
	1704	+
	1705	+	synthesis. "Manufacturer" includes any person who packages,
	1706	+	repackages or labels any container of any controlled dangerous
	1707	+	substance, except practitioners who dispense or compound
	1708	+	prescription orders for delivery to the ultimate consumer;
	1709	+	23. "Marijuana" means all parts of the plant Cannabis sativa
	1710	+	L., whether growing or not; the seeds thereof; the resin extracted
	1711	+	from any part of such plant; and every compound, manufacture, salt,
	1712	+	derivative, mixture or preparation of such plant, its seeds or
	1713	+	resin, but shall not include:
	1714	+	a. the mature stalks of such plant or fiber produced from
	1715	+	such stalks,
	1716	+	b. oil or cake made from the seeds of such plant,
	1717	+	including cannabidiol derived from the seeds of the
	1718	+	marijuana plant,
	1719	+	c. any other compound, manufacture, salt, derivative,
	1720	+	mixture or preparation of such mature stalks (except
	1721	+	the resin extracted therefrom), including cannabidiol
	1722	+	derived from mature stalks, fiber, oil or cake,
	1723	+	d. the sterilized seed of such plant which is incapable
	1724	+	of germination,
	1725	+	e. for any person participating in a clinical trial to
	1726	+	administer cannabidiol for the treatment of severe
	1727	+	forms of epilepsy pursuant to Section 2-802 of this
	1728	+	title, a drug or substance approved by the federal
	1729	+
	1730	+	ENGR. H. B. NO. 2281 Page 9 1
	1731	+	2
	1732	+	3
	1733	+	4
	1734	+	5
	1735	+	6
	1736	+	7
	1737	+	8
	1738	+	9
	1739	+	10
	1740	+	11
	1741	+	12
	1742	+	13
	1743	+	14
	1744	+	15
	1745	+	16
	1746	+	17
	1747	+	18
	1748	+	19
	1749	+	20
	1750	+	21
	1751	+	22
	1752	+	23
	1753	+	24
	1754	+
	1755	+	Food and Drug Administration for use by those
	1756	+	participants,
254	1757		f. for any person or the parents, legal guardians or
255	1758		caretakers of the person who have received a written
256	1759		certification from a physician licensed in this state
257	1760		that the person has been diagnosed by a physician as
258	1761		having Lennox-Gastaut syndrome, Dravet syndrome, also
259	1762		known as severe myoclonic epilepsy of infancy, or any
260	1763		other severe form of epilepsy that is not adequately
261	1764		treated by traditional medical therapies, spasticity
262	1765		due to multiple sclerosis or due to paraplegia,
263	1766		intractable nausea and vomiting, appetite stimulation
264	1767		with chronic wasting diseases, the substance
265	1768		cannabidiol, a nonpsychoactive cannabinoid, found in
266	1769		the plant Cannabis sativa L. or any other preparation
267	1770		thereof, that has a tetrahydrocannabinol concentration
268	1771		of not more than three-tenths of one percent (0.3%)
269	1772		and that is delivered to the patient in the form of a
270		-	liquid, ENR. H. B. NO. 2281 Page 7
271		-
	1773	+	liquid,
272	1774		g. any federal Food-and-Drug-Administration-approved drug
273	1775		or substance, or
274		-
275	1776		h. industrial hemp, from the plant Cannabis sativa L. and
276	1777		any part of such plant, whether growing or not, with a
277	1778		delta-9 tetrahydrocannabinol concentration of not more
	1779	+
	1780	+	ENGR. H. B. NO. 2281 Page 10 1
	1781	+	2
	1782	+	3
	1783	+	4
	1784	+	5
	1785	+	6
	1786	+	7
	1787	+	8
	1788	+	9
	1789	+	10
	1790	+	11
	1791	+	12
	1792	+	13
	1793	+	14
	1794	+	15
	1795	+	16
	1796	+	17
	1797	+	18
	1798	+	19
	1799	+	20
	1800	+	21
	1801	+	22
	1802	+	23
	1803	+	24
	1804	+
278	1805		than three-tenths of one percent (0.3%) on a dry-
279	1806		weight basis which shall only be grown pursuant to the
280	1807		Oklahoma Industrial Hemp Program and may be shipped
281	1808		intrastate and interstate;
282		-
283		-	24. “Medical purpose” means an intention to utilize a
	1809	+	24. "Medical purpose" means an intention to utilize a
284	1810		controlled dangerous substance for physical or mental treatment, for
285	1811		diagnosis, or for the prevention of a disease condition not in
286	1812		violation of any state or federal law and not for the purpose of
287	1813		satisfying physiological or psychological depe ndence or other abuse;
288		-
289		-	25. “Mid-level practitioner” means an Advanced Practice
	1814	+	25. "Mid-level practitioner" means an Advanced Practice
290	1815		Registered Nurse as defined and within parameters specified in
291	1816		Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
292	1817		animal euthanasia technician as defined in Se ction 698.2 of Title 59
293	1818		of the Oklahoma Statutes, or an animal control officer registered by
294	1819		the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
295	1820		under subsection B of Section 2-301 of this title within the
296		-	parameters of such officer’s duties under Sections 501 through 508
	1821	+	parameters of such officer's duties under Sections 501 through 508
297	1822		of Title 4 of the Oklahoma Statutes;
298		-
299		-	26. “Narcotic drug” means any of the following, whether
	1823	+	26. "Narcotic drug" means any of the following, whether
300	1824		produced directly or indirectly by extraction from substances of
301	1825		vegetable origin, or independently by means of chemical synthesis ,
302	1826		or by a combination of extraction and chemical synthesis:
303		-
304	1827		a. opium, coca leaves and opiates,
	1828	+
	1829	+	ENGR. H. B. NO. 2281 Page 11 1
	1830	+	2
	1831	+	3
	1832	+	4
	1833	+	5
	1834	+	6
	1835	+	7
	1836	+	8
	1837	+	9
	1838	+	10
	1839	+	11
	1840	+	12
	1841	+	13
	1842	+	14
	1843	+	15
	1844	+	16
	1845	+	17
	1846	+	18
	1847	+	19
	1848	+	20
	1849	+	21
	1850	+	22
	1851	+	23
	1852	+	24
305	1853
306	1854		b. a compound, manufacture, salt, derivative or
307	1855		preparation of opium, coca leaves or opiates,
308		-
309	1856		c. cocaine, its salts, optical and geometric isomers, and
310	1857		salts of isomers,
311		-
312	1858		d. ecgonine, its derivatives, their salts, isomers and
313	1859		salts of isomers, and
314		-	ENR. H. B. NO. 2281 Page 8
315	1860		e. a substance, and any compound, manufacture, salt,
316	1861		derivative or preparation thereof, which is chemically
317	1862		identical with any of the substances referred to in
318	1863		subparagraphs a through d of this paragraph, except
319		-	that the words “narcotic drug” narcotic drug as used
320		-	in Section 2-101 et seq. of this title shall not
321		-	include decocainized coca leaves or extracts of coca
322		-	leaves, which extracts do not contain cocaine or
323		-	ecgonine;
324		-
325		-	27. “Opiate” or “opioid” means any Schedule II, III, IV or V
	1864	+	that the words "narcotic drug" as used in Section 2-
	1865	+	101 et seq. of this title shall not include
	1866	+	decocainized coca leaves or extracts of coca leaves,
	1867	+	which extracts do not contain cocaine or ecgonine;
	1868	+	27. "Opiate" or "opioid" means any Schedule II, III, IV or V
326	1869		substance having an addiction-forming or addiction-sustaining
327	1870		liability similar to morphine or being capable of conversion into a
328	1871		drug having such addiction-forming or addiction-sustaining
329	1872		liability. The terms do not include, unless specifically designated
330	1873		as controlled under the Uniform Controlled Dangerous Substances Act,
331	1874		the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
332	1875		salts (dextromethorphan). The terms do include the racemic and
333	1876		levorotatory forms;
334	1877
335		-	28. “Opium poppy” means the plant of the species Papaver
	1878	+	ENGR. H. B. NO. 2281 Page 12 1
	1879	+	2
	1880	+	3
	1881	+	4
	1882	+	5
	1883	+	6
	1884	+	7
	1885	+	8
	1886	+	9
	1887	+	10
	1888	+	11
	1889	+	12
	1890	+	13
	1891	+	14
	1892	+	15
	1893	+	16
	1894	+	17
	1895	+	18
	1896	+	19
	1897	+	20
	1898	+	21
	1899	+	22
	1900	+	23
	1901	+	24
	1902	+
	1903	+	28. "Opium poppy" means the plant of the species Papaver
336	1904		somniferum L., except the seeds thereof;
337		-
338		-	29. “Peace officer” means a police officer, sheriff, deputy
339		-	sheriff, district attorney’s investigator, investigator from the
	1905	+	29. "Peace officer" means a police officer, sheriff, deputy
	1906	+	sheriff, district attorney's investigator, investigator from the
340	1907		Office of the Attorney General, or any other person elected or
341	1908		appointed by law to enforce any of the criminal laws of this state
342	1909		or of the United States;
343		-
344		-	30. “Person” means an individual, corporation, government or
	1910	+	30. "Person" means an individual, corporation, government or
345	1911		governmental subdivision or agency, business trust, estat e, trust,
346	1912		partnership or association, or any other legal entity;
347		-
348		-	31. “Poppy straw” means all parts, except the seeds, of the
	1913	+	31. "Poppy straw" means all parts, except the seeds, of the
349	1914		opium poppy, after mowing;
350		-
351		-	32. “Practitioner” means:
352		-
	1915	+	32. "Practitioner" means:
353	1916		a. (1) a medical doctor or osteopathic physician,
354		-
355	1917		(2) a dentist,
356		-
357	1918		(3) a podiatrist,
358		-
359		-	(4) an optometrist, ENR. H. B. NO. 2281 Page 9
360		-
	1919	+	(4) an optometrist,
361	1920		(5) a veterinarian,
362		-
363	1921		(6) a physician assistant or Advanced Practice
364	1922		Registered Nurse under the supervision of a
365	1923		licensed medical doctor or osteopathic physician,
366		-
367	1924		(7) a scientific investigator, or
368		-
369	1925		(8) any other person,
	1926	+
	1927	+	ENGR. H. B. NO. 2281 Page 13 1
	1928	+	2
	1929	+	3
	1930	+	4
	1931	+	5
	1932	+	6
	1933	+	7
	1934	+	8
	1935	+	9
	1936	+	10
	1937	+	11
	1938	+	12
	1939	+	13
	1940	+	14
	1941	+	15
	1942	+	16
	1943	+	17
	1944	+	18
	1945	+	19
	1946	+	20
	1947	+	21
	1948	+	22
	1949	+	23
	1950	+	24
370	1951
371	1952		licensed, registered or otherwise permitted to
372	1953		prescribe, distribute, dispense, conduct research with
373	1954		respect to, use for scientific purposes or administer
374	1955		a controlled dangerous substance in the course of
375	1956		professional practice or research in this state, or
376		-
377	1957		b. a pharmacy, hospital, laboratory or other institution
378	1958		licensed, registered or otherwise permitted to
379	1959		distribute, dispense, conduct research with respect
380	1960		to, use for scientific purposes or administer a
381	1961		controlled dangerous substance in the course of
382	1962		professional practice or research in this state;
383		-
384		-	33. “Production” includes the manufacture, planting,
	1963	+	33. "Production" includes the manufacture, planting,
385	1964		cultivation, growing or harvesting of a controlled dangerous
386	1965		substance;
387		-
388		-	34. “State” means the State of Oklahoma or any other state of
	1966	+	34. "State" means the State of Oklahoma or any other state of
389	1967		the United States;
390		-
391		-	35. “Ultimate user” means a person who lawfully possesses a
392		-	controlled dangerous substance for the person’s own use or for the
393		-	use of a member of the person’s household or for administration to
394		-	an animal owned by the person or by a member of the person’s
	1968	+	35. "Ultimate user" means a person who lawfully possesses a
	1969	+	controlled dangerous substance for the person's own use or for the
	1970	+	use of a member of the person's household or for administration to
	1971	+	an animal owned by the person or by a member of the person's
395	1972		household;
396		-
397		-	36. “Drug paraphernalia” means all equipment, products and
	1973	+	36. "Drug paraphernalia" means all equipment, products and
398	1974		materials of any kind which are used, intended for use, or fashioned
399	1975		specifically for use in planting, propagating, cultivating, growing,
	1976	+
	1977	+	ENGR. H. B. NO. 2281 Page 14 1
	1978	+	2
	1979	+	3
	1980	+	4
	1981	+	5
	1982	+	6
	1983	+	7
	1984	+	8
	1985	+	9
	1986	+	10
	1987	+	11
	1988	+	12
	1989	+	13
	1990	+	14
	1991	+	15
	1992	+	16
	1993	+	17
	1994	+	18
	1995	+	19
	1996	+	20
	1997	+	21
	1998	+	22
	1999	+	23
	2000	+	24
	2001	+
400	2002		harvesting, manufacturing, compounding, converting, producin g,
401	2003		processing, preparing, testing, analyzing, packaging, repackaging,
402	2004		storing, containing, concealing, injecting, ingesting, inhaling or
403		-	otherwise introducing into the human body, a controlled dangerous ~~ENR. H. B. NO. 2281 Page 10~~
	2005	+	otherwise introducing into the human body, a controlled dangerous
404	2006		substance in violation of the Uniform Controlled Dang erous
405	2007		Substances Act including, but not limited to:
406		-
407	2008		a. kits used, intended for use, or fashioned specifically
408	2009		for use in planting, propagating, cultivating, growing
409	2010		or harvesting of any species of plant which is a
410	2011		controlled dangerous substance or from whi ch a
411	2012		controlled dangerous substance can be derived,
412		-
413	2013		b. kits used, intended for use, or fashioned specifically
414	2014		for use in manufacturing, compounding, converting,
415	2015		producing, processing or preparing controlled
416	2016		dangerous substances,
417		-
418	2017		c. isomerization devices us ed, intended for use, or
419	2018		fashioned specifically for use in increasing the
420	2019		potency of any species of plant which is a controlled
421	2020		dangerous substance,
422		-
423	2021		d. testing equipment used, intended for use, or fashioned
424	2022		specifically for use in identifying, or in analyz ing
425	2023		the strength, effectiveness or purity of controlled
426	2024		dangerous substances,
427	2025
	2026	+	ENGR. H. B. NO. 2281 Page 15 1
	2027	+	2
	2028	+	3
	2029	+	4
	2030	+	5
	2031	+	6
	2032	+	7
	2033	+	8
	2034	+	9
	2035	+	10
	2036	+	11
	2037	+	12
	2038	+	13
	2039	+	14
	2040	+	15
	2041	+	16
	2042	+	17
	2043	+	18
	2044	+	19
	2045	+	20
	2046	+	21
	2047	+	22
	2048	+	23
	2049	+	24
	2050	+
428	2051		e. scales and balances used, intended for use, or
429	2052		fashioned specifically for use in weighing or
430	2053		measuring controlled dangerous substances,
431		-
432	2054		f. diluents and adulterants, such as qu inine
433	2055		hydrochloride, mannitol, mannite, dextrose and
434	2056		lactose, used, intended for use, or fashioned
435	2057		specifically for use in cutting controlled dangerous
436	2058		substances,
437		-
438	2059		g. separation gins and sifters used, intended for use, or
439	2060		fashioned specifically for use in removing twigs and
440	2061		seeds from, or in otherwise cleaning or refining,
441	2062		marijuana,
442		-
443	2063		h. blenders, bowls, containers, spoons and mixing devices
444	2064		used, intended for use, or fashioned specifically for
445	2065		use in compounding controlled dangerous substances,
446		-
447	2066		i. capsules, balloons, envelopes and other containers
448		-	used, intended for use, or fashioned specifically for ~~ENR. H. B. NO. 2281 Page 11~~
	2067	+	used, intended for use, or fashioned specifically for
449	2068		use in packaging small quantities of controlled
450	2069		dangerous substances,
451		-
452	2070		j. containers and other objects used, intended for use,
453	2071		or fashioned specifically for use in parenterally
454	2072		injecting controlled dangerous substances into the
455	2073		human body,
456	2074
	2075	+	ENGR. H. B. NO. 2281 Page 16 1
	2076	+	2
	2077	+	3
	2078	+	4
	2079	+	5
	2080	+	6
	2081	+	7
	2082	+	8
	2083	+	9
	2084	+	10
	2085	+	11
	2086	+	12
	2087	+	13
	2088	+	14
	2089	+	15
	2090	+	16
	2091	+	17
	2092	+	18
	2093	+	19
	2094	+	20
	2095	+	21
	2096	+	22
	2097	+	23
	2098	+	24
	2099	+
457	2100		k. hypodermic syringes, needles and other objects used,
458	2101		intended for use, or fashioned specifically for use in
459	2102		parenterally injecting controlled dangerous substances
460	2103		into the human body,
461		-
462	2104		l. objects used, intended for use, or fashioned
463	2105		specifically for use in ingesting, inhaling or
464	2106		otherwise introducing marijuana, cocaine, hashish or
465	2107		hashish oil into the human body, such as:
466		-
467	2108		(1) metal, wooden, acrylic, glass, stone, plastic or
468	2109		ceramic pipes with or without screens, permanent
469	2110		screens, hashish heads or punctured metal bowls,
470		-
471	2111		(2) water pipes,
472		-
473	2112		(3) carburetion tubes and devices,
474		-
475	2113		(4) smoking and carburetion masks,
476		-
477	2114		(5) roach clips, meaning objects used to hold burning
478	2115		material, such as a marijuana cigarette, that has
479	2116		become too small or too short to be held in the
480	2117		hand,
481		-
482	2118		(6) miniature cocaine spoons and cocaine vials,
483		-
484	2119		(7) chamber pipes,
485		-
486	2120		(8) carburetor pipes,
487		-
488	2121		(9) electric pipes,
489		-
490	2122		(10) air-driven pipes,
491		-
492	2123		(11) chillums,
493		-	ENR. H. B. NO. 2281 Page 12
	2124	+
	2125	+	ENGR. H. B. NO. 2281 Page 17 1
	2126	+	2
	2127	+	3
	2128	+	4
	2129	+	5
	2130	+	6
	2131	+	7
	2132	+	8
	2133	+	9
	2134	+	10
	2135	+	11
	2136	+	12
	2137	+	13
	2138	+	14
	2139	+	15
	2140	+	16
	2141	+	17
	2142	+	18
	2143	+	19
	2144	+	20
	2145	+	21
	2146	+	22
	2147	+	23
	2148	+	24
	2149	+
494	2150		(12) bongs, or
495		-
496	2151		(13) ice pipes or chillers,
497		-
498	2152		m. all hidden or novelty pipes, and
499		-
500	2153		n. any pipe that has a tobacco bowl or chamber of less
501	2154		than one-half (1/2) inch in diameter in which there is
502	2155		any detectable residue of any controlled dangerous
503	2156		substance as defined in this section or any other
504	2157		substances not legal for possession or use;
505		-
506		-	provided, however, the term “drug paraphernalia” drug paraphernalia
507		-	shall not include separation gins intended for use in preparing tea
508		-	or spice, clamps used for constructing electrical equipment, water
509		-	pipes designed for ornamentation in which no detectable amount of an
510		-	illegal substance is found or pipes designed and used solely for
511		-	smoking tobacco, traditional pipes of an American Indian tribal
512		-	religious ceremony, or antique pipes that are thirty (30) years of
513		-	age or older;
514		-
515		-	37. a. “Synthetic controlled substance” means a substance:
516		-
	2158	+	provided, however, the term "drug paraphernalia" shall not include
	2159	+	separation gins intended for use in preparing tea or spice, clamps
	2160	+	used for constructing electrical equipment, water pipes designed for
	2161	+	ornamentation in which no detectable amount of an illegal substance
	2162	+	is found or pipes designed and used solely for smoking tobacco,
	2163	+	traditional pipes of an American Indian tribal religious ceremony,
	2164	+	or antique pipes that are thirty (30) years of age or older;
	2165	+	37. a. "Synthetic controlled substance" means a substance:
517	2166		(1) the chemical structure of which is substantially
518	2167		similar to the chemical structure of a controlled
519	2168		dangerous substance in Schedule I or II,
520		-
521	2169		(2) which has a stimulant, depressant, or
522	2170		hallucinogenic effect on the central nervous
523	2171		system that is substantially similar to or
524	2172		greater than the stimulant, depressant or
525	2173		hallucinogenic effect on the central nervous
	2174	+
	2175	+	ENGR. H. B. NO. 2281 Page 18 1
	2176	+	2
	2177	+	3
	2178	+	4
	2179	+	5
	2180	+	6
	2181	+	7
	2182	+	8
	2183	+	9
	2184	+	10
	2185	+	11
	2186	+	12
	2187	+	13
	2188	+	14
	2189	+	15
	2190	+	16
	2191	+	17
	2192	+	18
	2193	+	19
	2194	+	20
	2195	+	21
	2196	+	22
	2197	+	23
	2198	+	24
	2199	+
526	2200		system of a controlled dangerous substance in
527	2201		Schedule I or II, or
528		-
529	2202		(3) with respect to a particular person, which such
530	2203		person represents or intends to have a stimulant,
531	2204		depressant, or hallucinogenic effect on the
532	2205		central nervous system that is substantially
533	2206		similar to or greater than the stimulant,
534	2207		depressant, or hallucinogenic effect on the
535	2208		central nervous system of a controlled dangerous
536	2209		substance in Schedule I or II.
537		-	ENR. H. B. NO. 2281 Page 13
538	2210		b. The designation of gamma butyrolactone or any other
539	2211		chemical as a precursor, pursuant to Section 2-322 of
540	2212		this title, does not preclude a finding pursuant to
541	2213		subparagraph a of this paragraph that the chemical is
542	2214		a synthetic controlled substance.
543		-
544		-	c. “Synthetic controlled substance” does not include:
545		-
	2215	+	c. "Synthetic controlled substance" does not include:
546	2216		(1) a controlled dangerous substance,
547		-
548	2217		(2) any substance for which there is an approved new
549	2218		drug application,
550		-
551	2219		(3) with respect to a particular person any
552	2220		substance, if an exemption is in effect for
553	2221		investigational use, for that person under the
554	2222		provisions of Section 505 of the Federal Food,
555	2223		Drug and Cosmetic Act, Title 21 of the United
	2224	+
	2225	+	ENGR. H. B. NO. 2281 Page 19 1
	2226	+	2
	2227	+	3
	2228	+	4
	2229	+	5
	2230	+	6
	2231	+	7
	2232	+	8
	2233	+	9
	2234	+	10
	2235	+	11
	2236	+	12
	2237	+	13
	2238	+	14
	2239	+	15
	2240	+	16
	2241	+	17
	2242	+	18
	2243	+	19
	2244	+	20
	2245	+	21
	2246	+	22
	2247	+	23
	2248	+	24
	2249	+
556	2250		States Code, Section 355, to the extent conduct
557	2251		with respect to such substance is pursuant to
558	2252		such exemption, or
559		-
560	2253		(4) any substance to the extent not intended for
561	2254		human consumption before such an exemption takes
562	2255		effect with respect to that substance.
563		-
564	2256		d. Prima facie evidence that a substance containing
565	2257		salvia divinorum has been enhanced, concentrated or
566	2258		chemically or physically altered shall give rise to a
567	2259		rebuttable presumption that the substance is a
568	2260		synthetic controlled substance;
569		-
570		-	38. “Tetrahydrocannabinols” means all substances that have been
	2261	+	38. "Tetrahydrocannabinols" means all substances that have been
571	2262		chemically synthesized to emulate the tetrahydrocannabinols of
572	2263		marijuana, specifically including any tetrahydrocannabinols derived
573	2264		from industrial hemp;
574		-
575		-	39. “Isomer” means the optical isomer, except as used in
	2265	+	39. "Isomer" means the optical isomer, except as used in
576	2266		subsections C and F of Section 2-204 of this title an d paragraph 4
577	2267		of subsection A of Section 2-206 of this title. As used in
578		-	subsections C and F of Section 2-204 of this title, “isomer” isomer
579		-	means the optical, positional or geometric isomer. As used in
580		-	paragraph 4 of subsection A of Section 2-206 of this title, the term
581		-	“isomer” isomer means the optical or geometric isomer;
582		-	ENR. H. B. NO. 2281 Page 14
583		-	40. “Hazardous materials” means materials, whether solid,
	2268	+	subsections C and F of Section 2-204 of this title, "isomer" means
	2269	+	the optical, positional or geometric isomer. As used in paragraph 4
	2270	+	of subsection A of Section 2-206 of this title, the term "isomer"
	2271	+	means the optical or geometric isomer;
	2272	+	40. "Hazardous materials" means materials, whether solid,
584	2273		liquid or gas, which are toxic to human, animal, aquatic or plant
	2274	+
	2275	+	ENGR. H. B. NO. 2281 Page 20 1
	2276	+	2
	2277	+	3
	2278	+	4
	2279	+	5
	2280	+	6
	2281	+	7
	2282	+	8
	2283	+	9
	2284	+	10
	2285	+	11
	2286	+	12
	2287	+	13
	2288	+	14
	2289	+	15
	2290	+	16
	2291	+	17
	2292	+	18
	2293	+	19
	2294	+	20
	2295	+	21
	2296	+	22
	2297	+	23
	2298	+	24
	2299	+
585	2300		life, and the disposal of which materials is controlled by state or
586	2301		federal guidelines;
587		-
588		-	41. “Anhydrous ammonia” means any substance that exhibits
	2302	+	41. "Anhydrous ammonia" means any substance that exhibits
589	2303		cryogenic evaporative behavior and tests positive for ammonia;
590		-
591		-	42. “Acute pain” means pain, whether resulting from disease,
	2304	+	42. "Acute pain" means pain, whether resulting from disease,
592	2305		accidental or intentional trauma or other cause, that th e
593	2306		practitioner reasonably expects to last only a short period of time.
594		-	“Acute pain” Acute pain does not include chronic pain, pain being
595		-	treated as part of cancer care, hospice or other end-of-life care,
596		-	or pain being treated as part of palliative care;
597		-
598		-	43. “Chronic pain” means pain that persists beyond the usual
599		-	course of an acute disease or healing of an injury. “Chronic pain”
600		-	Chronic pain may or may not be associated with an acute or chronic
601		-	pathologic process that causes continuous or intermittent pain over
602		-	months or years;
603		-
604		-	44. “Initial prescription” means a prescription issued to a
	2307	+	"Acute pain" does not include chronic pain, pain being treated as
	2308	+	part of cancer care, hospice or other end-of-life care, or pain
	2309	+	being treated as part of palliative care;
	2310	+	43. "Chronic pain" means pain that persists beyond the usual
	2311	+	course of an acute disease or healing of an injury. "Chronic pain"
	2312	+	may or may not be associated with an acute or chronic pathologic
	2313	+	process that causes continuous or intermittent pain over months or
	2314	+	years;
	2315	+	44. "Initial prescription" means a prescription issued to a
605	2316		patient who:
606		-
607	2317		a. has never previously been issued a prescription for
608	2318		the drug or its pharmaceutical equivalent in the past
609	2319		year, or
610		-
611	2320		b. requires a prescription for the drug or its
612	2321		pharmaceutical equivalent due to a surgical procedure
613	2322		or new acute event and has previously had a
	2323	+
	2324	+	ENGR. H. B. NO. 2281 Page 21 1
	2325	+	2
	2326	+	3
	2327	+	4
	2328	+	5
	2329	+	6
	2330	+	7
	2331	+	8
	2332	+	9
	2333	+	10
	2334	+	11
	2335	+	12
	2336	+	13
	2337	+	14
	2338	+	15
	2339	+	16
	2340	+	17
	2341	+	18
	2342	+	19
	2343	+	20
	2344	+	21
	2345	+	22
	2346	+	23
	2347	+	24
	2348	+
614	2349		prescription for the drug or its pharmaceutical
615	2350		equivalent within the past year.
616		-
617	2351		When determining whether a patient was previously issued a
618	2352		prescription for a drug or its pha rmaceutical equivalent, the
619	2353		practitioner shall consult with the patient and review the medical
620	2354		record and prescription monitoring information of the patient;
621		-
622		-	45. “Patient-provider agreement” means a written contract or
	2355	+	45. "Patient-provider agreement" means a written contract or
623	2356		agreement that is executed between a practitioner and a patient,
624	2357		prior to the commencement of treatment for chronic pain using an
625	2358		opioid drug as a means to:
626		-	ENR. H. B. NO. 2281 Page 15
627	2359		a. explain the possible risk of development of physical
628	2360		or psychological dependence in the patient and prevent
629	2361		the possible development of addiction,
630		-
631	2362		b. document the understanding of both the practitioner
632	2363		and the patient regarding the patient-provider
633	2364		agreement of the patient,
634		-
635	2365		c. establish the rights of the patient in association
636	2366		with treatment and the obligations of the patient in
637	2367		relation to the responsible use, discontinuation of
638	2368		use, and storage of opioid drugs, including any
639	2369		restrictions on the refill of prescriptions or the
640	2370		acceptance of opioid prescriptions from practitioners,
641		-
642	2371		d. identify the specific medications and other modes of
643	2372		treatment, including physical therapy or exercise,
	2373	+
	2374	+	ENGR. H. B. NO. 2281 Page 22 1
	2375	+	2
	2376	+	3
	2377	+	4
	2378	+	5
	2379	+	6
	2380	+	7
	2381	+	8
	2382	+	9
	2383	+	10
	2384	+	11
	2385	+	12
	2386	+	13
	2387	+	14
	2388	+	15
	2389	+	16
	2390	+	17
	2391	+	18
	2392	+	19
	2393	+	20
	2394	+	21
	2395	+	22
	2396	+	23
	2397	+	24
	2398	+
644	2399		relaxation or psychological counseling, that are
645	2400		included as a part of the patient-provider agreement,
646		-
647	2401		e. specify the measures the practitioner may employ to
648	2402		monitor the compliance of the patient including , but
649	2403		not limited to, random specimen screens and pill
650	2404		counts, and
651		-
652	2405		f. delineate the process for terminating the agreement,
653	2406		including the consequences if the practitioner has
654	2407		reason to believe that the patient is not complying
655	2408		with the terms of the agreemen t. Compliance with the
656		-	“consent items” shall constitute a valid, informed
	2409	+	"consent items" shall constitute a valid, informed
657	2410		consent for opioid therapy. The practitioner shall be
658	2411		held harmless from civil litigation for failure to
659	2412		treat pain if the event occurs because of nonadherence
660	2413		by the patient with any of the provisions of the
661	2414		patient-provider agreement;
662		-
663		-	46. “Serious illness” means a medical illness or physical
	2415	+	46. "Serious illness" means a medical illness or physical
664	2416		injury or condition that substantially affects quality of life for
665		-	more than a short period of time. “Serious illness” Serious illness
666		-	includes, but is not limited to, Alzheimer’s disease or related
667		-	dementias, lung disease, cancer, heart failure, renal failure, liver
668		-	failure or chronic, unremitting or intractable pain such as
669		-	neuropathic pain; and
670		-	ENR. H. B. NO. 2281 Page 16
671		-	47. “Surgical procedure” means a procedure that is performed
	2417	+	more than a short period of time. "Serious illness" includes, but
	2418	+	is not limited to, Alzheimer's disease or related dementias, lung
	2419	+	disease, cancer, heart failure, renal failure, liver failure or
	2420	+	chronic, unremitting or intractable pain such as neuropathic pain;
	2421	+	and
	2422	+
	2423	+	ENGR. H. B. NO. 2281 Page 23 1
	2424	+	2
	2425	+	3
	2426	+	4
	2427	+	5
	2428	+	6
	2429	+	7
	2430	+	8
	2431	+	9
	2432	+	10
	2433	+	11
	2434	+	12
	2435	+	13
	2436	+	14
	2437	+	15
	2438	+	16
	2439	+	17
	2440	+	18
	2441	+	19
	2442	+	20
	2443	+	21
	2444	+	22
	2445	+	23
	2446	+	24
	2447	+
	2448	+	47. "Surgical procedure" means a procedure that is performed
672	2449		for the purpose of structurally altering the human body by incision
673	2450		or destruction of tissues as part of the practice of medicine. This
674	2451		term includes the diagnostic or therapeutic treatment of conditions
675	2452		or disease processes by use of instruments such as lasers,
676	2453		ultrasound, ionizing, radiation, scalpels, probes or needles that
677	2454		cause localized alteration or transportation of live human tissue by
678	2455		cutting, burning, vaporizing, freezing, suturing, probing or
679	2456		manipulating by closed reduction for major dislocat ions or
680	2457		fractures, or otherwise altering by any mechanical, thermal, light-
681	2458		based, electromagnetic or chemical means; and
682		-
683		-	48. “Straw person” or “straw party” also known as a “front”
684		-	means a third party who:
685		-
686		-	a. is put up in name only to take part in a transact ion
687		-	or otherwise is a nominal party to a transaction,
688		-
689		-	b. acts on behalf of another person to obtain title to
690		-	property and executes documents and instruments the
691		-	principal may direct respecting property, or
692		-
693		-	c. purchases property for another for the purpose of
694		-	concealing the identity of the real purchaser or to
695		-	accomplish some purpose otherwise in violation of
696		-	Oklahoma Statutes.
697		-
698		-	SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -406, is
	2459	+	48. "Straw person" or "straw party" also known as a "front"
	2460	+	means a third party who is put up in name only to take part in a
	2461	+	transaction or is a nominal party to a transaction. The term also
	2462	+	means one who acts as an agent for another for the purpose of taking
	2463	+	title to property and executing whatever documents and instruments
	2464	+	the principal may direct respecting the property. A person who
	2465	+	purchases property for another to conceal the identity of the real
	2466	+	purchaser or to accomplish some purpose otherwise not allowed is
	2467	+	also known as a "straw person" or "straw party".
	2468	+	SECTION 5. AMENDATORY 63 O.S. 2021, Section 2 -406, is
699	2469		amended to read as follows:
700		-
701	2470		Section 2-406. A. It shall be unlawful for any registrant
702	2471		knowingly or intentionally:
703	2472
	2473	+	ENGR. H. B. NO. 2281 Page 24 1
	2474	+	2
	2475	+	3
	2476	+	4
	2477	+	5
	2478	+	6
	2479	+	7
	2480	+	8
	2481	+	9
	2482	+	10
	2483	+	11
	2484	+	12
	2485	+	13
	2486	+	14
	2487	+	15
	2488	+	16
	2489	+	17
	2490	+	18
	2491	+	19
	2492	+	20
	2493	+	21
	2494	+	22
	2495	+	23
	2496	+	24
	2497	+
704	2498		1. To distribute, other than by dispensing or as otherwise
705		-	authorized by this act the Uniform Controlled Dangerous Substances
706		-	Act, a controlled dangerous substance classified in Sc hedules I or
707		-	II, in the course of his or her legitimate business, except pursuant
708		-	to an order form as required by Section 2 -308 of this title;
709		-
	2499	+	authorized by this act, a contr olled dangerous substance classified
	2500	+	in Schedules I or II, in the course of his or her legitimate
	2501	+	business, except pursuant to an order form as required by Section 2 -
	2502	+	308 of this title;
710	2503		2. To use in the course of the manufacture or distribution of a
711	2504		controlled dangerous substance a registration nu mber which is
712	2505		fictitious, revoked, suspended or issued t o another person;
713		-	ENR. H. B. NO. 2281 Page 17
714	2506		3. To acquire or obtain possession of a controlled dangerous
715	2507		substance by misrepresentation, fraud, forgery, deception or
716	2508		subterfuge;
717		-
718	2509		4. To furnish false or fraudulent material inf ormation in, or
719	2510		omit any material information from, any application, report, or
720		-	other document required to be kept or filed under this act the
721		-	Uniform Controlled Dangerous Substances Act, or any record required
722		-	to be kept by this act the Uniform Controlled Dangerous Substances
723		-	Act; and
724		-
	2511	+	other document required to be kept or filed under this act, or any
	2512	+	record required to be kept by this act; and
725	2513		5. To make, distribute , or possess any punch, die, plate,
726	2514		stone, or other thing designed to print, imprint, or reproduce the
727	2515		trademark, trade name, or other identifying mark, imprint, or device
728	2516		of another or any likeness of any of the foregoing upon any drug or
729	2517		container or labeling thereof so as to render such drug a
730	2518		counterfeit controlled dangerous substance; and
731		-
732	2519		6. To purchase, or attempt, endeavor, or conspire to obtain or
733	2520		purchase, any license or registration require d to distribute,
734	2521		possess, prescribe, or manufacture any c ontrolled dangerous
	2522	+
	2523	+	ENGR. H. B. NO. 2281 Page 25 1
	2524	+	2
	2525	+	3
	2526	+	4
	2527	+	5
	2528	+	6
	2529	+	7
	2530	+	8
	2531	+	9
	2532	+	10
	2533	+	11
	2534	+	12
	2535	+	13
	2536	+	14
	2537	+	15
	2538	+	16
	2539	+	17
	2540	+	18
	2541	+	19
	2542	+	20
	2543	+	21
	2544	+	22
	2545	+	23
	2546	+	24
	2547	+
735	2548		substance on behalf of, or at the request or demand of, any other
736	2549		person through the use of a straw person or straw party.
737		-
738	2550		B. Any person who violates this section is guilty of a felony
739	2551		punishable by imprisonment for not more than twent y (20) years or a
740	2552		fine of not more than Tw o Hundred Fifty Thousand Dollars
741	2553		($250,000.00), or both.
742		-
743	2554		C. Any person convicted of a second or subsequent violation of
744	2555		this section is punishable by a term of imprisonment twice that
745	2556		otherwise authorized and by t wice the fine otherwise authorized.
746	2557		Convictions for second or subsequent violations of this section
747	2558		shall not be subject to statutory provisions for suspended
748	2559		sentences, deferred sentences, or probation.
749		-
750	2560		D. Any person convicted of any offense described in this
751	2561		section shall, in addition to any fi ne imposed, pay a special
752	2562		assessment trauma-care fee of One Hundred Dollars ($100.00) to be
753	2563		deposited into the Trauma Care Assistance Revolving Fund created in
754	2564		Section 1-2522 1-2530.9 of this title.
755		-
756		-	SECTION 3. It being immediately necessar y for the preservation
757		-	of the public peace, health or safety, an emergency is hereby ENR. H. B. NO. 2281 Page 18
	2565	+	SECTION 6. It being immediately necessar y for the preservation
	2566	+	of the public peace, health or safety, an emergency is hereby
758	2567		declared to exist, by reason whereof this act shall take effect and
759	2568		be in full force from and after its passage an d approval.
760		-	ENR. H. B. NO. 2281 Page 19
761		-
762		-	Passed the House of Representatives the 9th day of May, 2023.
	2569	+
	2570	+	ENGR. H. B. NO. 2281 Page 26 1
	2571	+	2
	2572	+	3
	2573	+	4
	2574	+	5
	2575	+	6
	2576	+	7
	2577	+	8
	2578	+	9
	2579	+	10
	2580	+	11
	2581	+	12
	2582	+	13
	2583	+	14
	2584	+	15
	2585	+	16
	2586	+	17
	2587	+	18
	2588	+	19
	2589	+	20
	2590	+	21
	2591	+	22
	2592	+	23
	2593	+	24
	2594	+
	2595	+	Passed the House of Representatives the 21st day of March, 2023.
	2596	+
763	2597
764	2598
765	2599
766	2600		Presiding Officer of the House
767	2601		of Representatives
768	2602
769	2603
770	2604
771		-	Passed the Senate the 25th day of April, 2023.
	2605	+	Passed the Senate the ___ day of __________, 2023.
	2606	+
772	2607
773	2608
774	2609
775	2610		Presiding Officer of the Senate
776	2611
777	2612
778	2613
779		-	OFFICE OF THE GOVERNOR
780		-	Received by the Office of the Governor this ____________________
781		-	day of ___________________, 20_______, at _______ o'clock _______ M.
782		-	By: _________________________________
783		-	Approved by the Governor of the State of Oklahoma this _____ ____
784		-	day of ___________________, 20_______, at _______ o'clock _______ M.
785		-
786		-
787		-	_________________________________
788		-	Governor of the State of Oklahoma
789		-
790		-	OFFICE OF THE SECRETARY OF STATE
791		-	Received by the Office of the Secretary of State this __________
792		-	day of ___________________, 20_______, at _______ o'clock _______ M.
793		-	By: _________________________________